X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/02/2855870/0/en/Fractyl-Health-Expands-Leadership-with-Appointment-of-Adrian-Kimber-as-Chief-Commercial-Officer-to-Spearhead-Anticipated-Launch-Preparation-as-the-Company-Conducts-Two-Pivotal-Stud.html
https://www.globenewswire.com/news-release/2024/04/01/2855076/0/en/Fractyl-Health-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2024/04/01/2855050/0/en/Fractyl-Health-Receives-FDA-IDE-Approval-for-the-Revita-Remain-1-Pivotal-Study-of-Weight-Maintenance-in-Obesity-after-Discontinuation-of-GLP-1-Based-Drugs.html
https://www.globenewswire.com//news-release/2024/03/12/2844941/0/en/UPDATE-Fractyl-Health-Announces-New-Results-From-Its-Rejuva-Platform-Demonstrating-Potent-and-Durable-Effects-of-a-Single-Dose-of-a-Human-GLP-1-Pancreatic-Gene-Therapy-Transgene-Co.html
https://www.globenewswire.com//news-release/2024/03/12/2844546/0/en/Fractyl-Health-Announces-New-Results-From-Its-Rejuva-Platform-Demonstrating-Potent-and-Durable-Effects-of-a-Single-Dose-of-a-Human-GLP-1-Pancreatic-Gene-Therapy-Transgene-Compared-.html
https://www.globenewswire.com//news-release/2024/02/20/2831869/0/en/Fractyl-Health-Appoints-Samuel-Conaway-to-Its-Board-of-Directors-Bolstering-New-Product-Commercial-Expertise-During-Revita-Pivotal-Clinical-Trials.html
https://www.reuters.com/business/healthcare-pharmaceuticals/fractyl-health-valued-6546-mln-tepid-debut-2024-02-02/
https://www.reuters.com/markets/deals/fractyl-health-targets-up-762-mln-valuation-us-ipo-2024-01-29/
https://www.reuters.com/markets/deals/fractyl-health-prices-us-ipo-below-range-raise-110-mln-2024-02-02/
https://www.fiercebiotech.com/biotech/alto-fractyl-head-public-markets-ipos-north-100m-each
Market Place
Share 
